gefitinib has been researched along with trimethoprim, sulfamethoxazole drug combination in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (trimethoprim, sulfamethoxazole drug combination) | Trials (trimethoprim, sulfamethoxazole drug combination) | Recent Studies (post-2010) (trimethoprim, sulfamethoxazole drug combination) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 7,527 | 875 | 2,260 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Barben, J; Manckoundia, P; Putot, A; Quipourt, V; Vovelle, J | 1 |
1 other study(ies) available for gefitinib and trimethoprim, sulfamethoxazole drug combination
Article | Year |
---|---|
Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib!
Topics: Aged, 80 and over; Antineoplastic Agents; COVID-19; Diagnostic Errors; Female; Gefitinib; Humans; Lung Neoplasms; Pneumocystis carinii; Pneumonia, Pneumocystis; SARS-CoV-2; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |